Abnova Taiwan Corp (4133)

Currency in TWD
21.55
+0.15(+0.70%)
Closed·
Trading near 52-week Low
High dividend Yield
4133 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
21.3021.85
52 wk Range
21.3035.10
Key Statistics
Bid/Ask
68.00 / 68.10
Prev. Close
28.3
Open
21.4
Day's Range
21.3-21.85
52 wk Range
21.3-35.1
Volume
141.92K
Average Volume (3m)
112.87K
1-Year Change
-24.2531%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4133 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Abnova Taiwan Corp News & Analysis

Show more
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Feb 25, 2026
EPS / Forecast
0,22 / --
Revenue / Forecast
83,94M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.02%
Dividend Yield
3.18%
Industry Median 0.54%
Annualised payout
0.90
Paid annually
5-Years Growth
-28.52%
Growth Streak

4133 Income Statement

Compare 4133 to Peers and Sector

Metrics to compare
4133
Peers
Sector
Relationship
P/E Ratio
−1,143.7x14.9x−0.5x
PEG Ratio
11.220.040.00
Price/Book
1.0x1.2x2.6x
Price / LTM Sales
3.7x3.4x3.2x
Upside (Analyst Target)
-27.3%47.8%
Fair Value Upside
Unlock26.2%5.9%Unlock

Abnova (Taiwan) Corporation engages in the research, development, manufacturing, and sales of monoclonal and multiclonal antibodies, proteins, medical diagnostic instruments, and testing reagents. The company’s products portfolio includes SARS-CoV/CoV-2, DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations. It also offers MaxPab, Nano, DNAxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies. In addition, the company provides integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; antibody production and scale up; assay development services; circulating tumor cell and DNA; germline genetic DNA; and FFPE tumor tissue DNA services. It serves academic, research institutions, and pharmaceutical factories. Abnova (Taiwan) Corporation was founded in 2002 and is headquartered in Taipei, Taiwan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
213,19K0,35%4,67M
Other Institutional Investors
9,42M15,56%206,32M
Public Companies & Retail Investors
50,92M84,09%1,12B
Total
60,55M100,00%1,33B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Kunmu Investment Co., Ltd.4,04%2 448 29453 618
Leishi Technology Co., Ltd.3,71%2 248 78649 248

FAQ

What Is the Abnova (4133) Stock Price Today?

The Abnova stock price today is 21,55 TWD.

What Stock Exchange Does Abnova Trade On?

Abnova is listed and trades on the Taiwan Stock Exchange.

What Is the Stock Symbol for Abnova?

The stock symbol for Abnova is "4133."

Does Abnova Pay Dividends? What’s The Current Dividend Yield?

The Abnova dividend yield is 4.11%.

What Is the Abnova Market Cap?

As of today, Abnova market cap is 1,33B TWD.

What Is Abnova's Earnings Per Share (TTM)?

The Abnova EPS (TTM) is -0,02.

From a Technical Analysis Perspective, Is 4133 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Abnova Stock Split?

Abnova has split 2 times.

What is the current trading status of Abnova (4133)?

As of May 06, 2026, Abnova (4133) is trading at a price of 21,55 TWD, with a previous close of 28,30 TWD. The stock has fluctuated within a day range of 21,30 TWD to 21,85 TWD, while its 52-week range spans from 21,30 TWD to 35,10 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.